Detect potential diversion earlier to improve safety and compliance
Despite 98% of healthcare executives agreeing that drug diversion occurs in hospitals, 79% believe that most drug diversion goes undetected. With Sentri7, detect drug diversion, bolster controlled substance compliance, and track medication inventory.
Sentri7 Drug Diversion (formerly Flowlytics from Invistics) is the only drug diversion software funded by the NIH
Utilizing machine learning, Sentri7 enables quick detection of potential diversion from purchase to the patient with predictive analytics and actionable dashboards. Sentri7 integrates data from multiple IT systems including Automated Dispensing Cabinet (ADC), Electronic Health Records (EHR), and other data systems to provide a comprehensive assessment of diversion risk across the entire supply chain.